this said to them unless the physician also says, "But I am willing to do whatever you feel is necessary. If there's an opportunity for some things to be done, we'll work with you. We'll attempt to do some things to help you." We have seen amazing things happen to patients when they're not just given up on. This is why I cannot embrace the concept of false hope.
Many people have different religious and spiritual orientations, so it is important for me to be sensitive to those. Before the 1990s, this was an uncomfortable subject. It was assumed that a pastor could not talk about different religious perspectives or different approaches to spirituality. It was assumed that no communication about these matters could be conducted unless the pastor, chaplain, or minister was clearly aligned with the same religion as the patient. The whole concept of spirituality has blossomed over the past decade. Now people are more likely to see the chaplain as someone who can work with a person no matter what the person's religious ties may be. Spirituality is no longer a taboo subject, one that can only be broached behind the closed doors of one's own religious institution. This allows people to have freer access to spirituality, particularly within the framework of the health care environment.
Returning to the breast cancer case, it is extremely important to try to get inside the patient's head to see how she sees herself, how she would like to be perceived, and how she would like to be supported spiritually. This allows her to move through diagnosis and treatment more effectively. I would ask her whether she had certain experiences she still wants to have, certain projects to pursue or friendships she wants to cultivate. Even though cancer patients may feel settled in who they are and how they look, they begin asking the deeper questions when they confront their own mortality. They may be asking, "Is this all there is?" We need to investigate what is her perception of life at this point in time, and how does she need to feel supported-not only as a cancer patient, but as a woman, as a wife, as a business person. Who she is should not be defined by her diagnosis. Nor should her disease nullify who she is in life and as a person. Who she is as a person should be celebrated and nurtured in ways that give her a sense of value, dignity, and purpose. We should aim to nurture her through the entire process of treatment and after treatment.
Rev. Percy McCray
Cancer Treatment Centers of America at Midwestern Regional Medical Center 2520 Elisha Avenue Zion, IL 60046 percy.mccray@mrmc-ctca.com.
Integrative Physician's Perspective

Medical Oncology
Dr Boasberg has provided a valuable analysis of this case. He appropriately points out the necessity for a full staging of the patient at this time. We agree with his comments that if primary resistance to Adriamycin and Cytoxan were observed, taxane therapy would be appropriate. We would add that melatonin 1 and fish oil 2 have demonstrated in vitro abilities to sensitize multidrug resistant tumor lines to the effects of chemotherapy. While Boasberg is correct that neoadjuvant therapy has not yet shown positive survival benefits in randomized trials, there is growing interest in this strategy due in part to recognized mechanisms of how malignant disease proliferates. The medical profession is just learning to modulate the internal environment by developing interventions to counteract resistant clones, growth factor stimulation, and angiogenesis. As more is learned in these areas it is likely that it will be possible to enhance the neoadjuvant effect, with a consequent shift toward more positive outcomes.
Radiation Oncology
It is refreshing and unusual to find a radiation oncologist-a group frequently regarded as technologyfocused-considering a program for fatigue that goes beyond simply assessing anemia and prescribing erythropoetin. It is especially interesting to find an oncologist adding Traditional Chinese Medicine (TCM) treatments to a fatigue program. Dr Sagar is a student of TCM, and has recently published a book on the subject of integrating TCM into integrative cancer care. 3 We heartily agree with his concerns about exercise and stress on the skeleton. Qigong and other exercise systems that have minimal impact on the skeleton are particularly suited to patients with bone metastases. Dr Sagar also points out that there are no clinical data at this time indicating interference between radiation therapy and oral antioxidant supplements. In spite of theoretical concerns recently raised, to date the preponderance of the existing evidence supports the use of antioxidants with both radiation and chemotherapy. Certainly more research should be undertaken to better resolve this important clinical issue.
Bristol Cancer Help Centre
Dr Miller's contribution focuses on emotional and spiritual issues and lifestyle factors that are in keeping with good integrative care. Her point about the value of giving the patient the opportunity to be truly heard by her physician is a good one. One of the casualties of managed care is the lack of time for direct physician-patient interaction; many integrative, complementary, and alternative practitioners are now trying to remedy this situation by spending the time with patients that optimized medicine demands. On the issue of soy consumption, we would refer readers to the Point Counter-Point article on the subject that appeared in the first issue of this journal. 4 Although we respect the concern and sensitivity, we do not feel that there are clinical data to support the warnings about vitamin C and chemotherapy interactions. Dr Miller recommends sessions of healing, one of the modes of nontouch energetic therapy. While the evidence base on techniques of this type is still quite small, and mechanisms are quite difficult to comprehend, it does appear that such treatments do result in relaxation, ease anxiety, and thus improve the patient's quality of life. 5
Naturopathic Medicine
Birdsall and colleagues have contributed a professional and evidence-based naturopathic assessment. Their supplement assessments were quite interesting: the discussion of use of ipriflavone exhibits some of the potential problems of using soy phytochemicals instead of whole soy foods. 4 The discussion of lean body mass, cachexia, and supplements shows the importance and the difficulty of counteracting cachexia. We definitely concur with the value of additional assessments of visceral proteins and other factors in the case of this weight-losing patient, including serum prealbumin, transferrin, TNFα and IL-6. It is appropriate to mention the anticachectic effect of fish oil, as well as the possibility that exercise focused on rebuilding muscle, if properly conducted, might contribute to counteracting cachexia.
Traditional Chinese Medicine
Wicke and Cheung have provided a fascinating and detailed analysis of this case that demonstrates the depth of clinical understanding and analysis that can result when TCM is applied by masters in the field. The TCM perspective, and the specific recommendations made, are clearly different from the Western perspective (readers who have difficulty with some of the concepts may find clarification in the article by Wicke and Cheung elsewhere in this issue). 6 There are specific questions that may arise about some of the herbal recommendations. Radix Aconiti, aconite root, is a well-known toxin. The form of aconite used in the recommendation of Wicke and Cheung, called "Praeparata" or prepared, has undergone lengthy cooking that detoxifies the poisonous alkaloids found in aconite, resulting in approximately a thousand-fold decrease in toxicity. In this form, aconite has been used safely, although cautiously, in TCM for hundreds of years. In Western medicine, we are quite familiar with the use of highly toxic medications for cancer. The remedies Eupolyphaga and Carapax Amydae are from animals (insects and turtles, respectively). The pharmacopoeia of TCM is large, about 6000 items. Of these, about 20% are actually from animals, and about 2% from minerals. The animal remedies are regarded in TCM as being particularly potent pharmacologically.
The usual TCM recommendation is that herbal and other remedies be taken as decoctions: in this form the medicinal substances are boiled for several hours and then strained out of the liquid, resulting in a very strong tea. The tastes of traditional decoctions are often unacceptable to those from Western cultures, making this a difficult form of medication to use for many. In Japanese "Kampo" herbal medicine, a new technique has been developed in which strong extracts of plants are spray-dried, and the resulting powder encapsulated to circumvent the strong tastes of decoctions.
Some idea of the complexity of TCM diagnosis and treatment may emerge for the reader in the discussion of feelings of cold and heat this patient reports. She usually feels cold "to the bone." However, during chemotherapy she experiences feelings of heat. In the TCM concept, chemotherapy frequently causes feelings of heat and induces symptoms that would be classified as "hot" symptoms, showing a need to be cooled. However, it is often the case that this heat during chemotherapy could mask an underlying deeper coldness, so that the practitioner in such a case would need to be careful not to cool the patient too much. We would note that radiation therapy also causes symptoms of heat, as discussed by Tran et al in the first issue of this journal. 7 The use of herbs concomitant with chemotherapy treatment also raises some concerns. Many articles in Chinese journals discuss trials of specific herbal combinations in conjunction with chemotherapy; this is a literature that is not yet well-known in the United States. However, due to concerns about herb-drug interactions, where experience is limited, it is a fairly common recommendation that patients cease herb use 1 day before a chemotherapy treatment and resume it 1 day after the end of the treatment. There is still much to learn about the potential for interactions (positive and negative) between Chinese herbs and conventional chemotherapy drugs.
Wicke and Cheung give a thorough analysis of the environmental issues (quality of air, light, water, etc) that might affect the cancer patient. In the TCM perspective, every food and medication has its own pattern of interaction with the body, a pattern that can promote or inhibit disease. The authors attend to these patterns closely. They provide what is perhaps one of the more cogent reasons for avoiding excessive soy, within the TCM perspective-its tendency to induce stagnation and dampness. In this article we see for the first time recommendations on the relevance of individually suited music therapy, a subject we hope to be able to explore more in the future. Although we would prefer to see more evidence-based references on this topic, we are pleased to note that they do not simply recommend listening to cheerful and calming music, but acknowledge the real advantage of listening under selected circumstances to emotionally tumultuous music to help bring to the surface suppressed feelings of anger. These authors have recognized the enormous variety of emotions expressed in music, and have matched musical selections to the patient's TCM diagnosis, a most interesting therapeutic strategy. Different patients, of course, with different TCM diagnostics, would need different music prescriptions.
Qigong Analysis
Qigong is one of the best-researched of the energyoriented therapies; one Qigong resource is a database of over 1300 published articles on Qigong medical research in China, including articles on the effects of Qigong on side effects of cancer chemotherapy. 8 As we pointed out above, Qigong is one of the exercise therapies that is likely to be particularly well suited to a skeletally compromised patient with bone metastases. He and Chen have given an interesting and challenging account of Master He's medical Qigong therapy. The manipulation of Qi, or vital energy, by physical and mental exercise, and the external manipulation of Qi in a patient by a master practitioner are definitely within the standard conceptions of TCM-although in the more esoteric reaches of that system. The claims of cancer recovery made by He and Chen still await documentation, and we are eager to see the results of the eventual clinical trials they are planning. In the meantime, it is important that integrative (and strictly conventional) practitioners make themselves aware of the nature of the Qigong system. It is also of interest to realize that many cancer patients in China practice Qigong as part of their disease treatment.
Integrative practitioners whose patients use a full medical Qigong program particularly need to attend to the dimension of fasting in the Bigu stage, a very strict water fast. While we are not in a position to challenge the value of this approach, having never observed patients undertaking such a fast, we raise the concern that patients who attempt this type of fast should most definitely be intensively monitored by their physician as well as their Qigong practitioners. Loss of weight, lean body mass, and visceral protein during fasting can impact outcome, response, and toleration of conventional therapies, and place patients in vulnerable and, at times, even life-threatening clinical situations. Thus, the decision to embark on a fast, and subsequent monitoring, need careful evaluation of a patient's clinical state and total plan of care.
He and Chen point out, in response to our expressed concerns, that it is suggested that patients try Bigu therapy only under an experienced Qigong master; meanwhile, once the patient chooses to do Bigu, she or he should be under the close supervision of a Qigong master, not the physician. . . . the Qigong master could handle any situation occurring during the Bigu, and medical interference of monitoring may actually bring more harm than benefits to the patient since most medical professionals do not know how Bigu works and how the patient may respond to the energy flow.
We certainly respect the assertion that the primary practitioner (in this case the Qigong Master) implementing a therapy in the care of a patient needs to be actively involved in determining whether a course of care is going as expected or if changes are needed. However, we would suggest that the education, involvement, and collaboration of all other significant practitioners should take place in any effective integrative care situation. We also respect the point that the Qigong instructor likely would have expertise in this area that other practitioners might be lacking, but we are unable to support the suggestion that the patient not be also under the supervision of the physician. Clinically significant events may occur, especially in a patient with advanced cancer, for which the Qigong practitioner is not trained in either recognition or treatment. This may place the patient at unnecessary risk. In a truly integrative and collaborative situation, though, an educated physician working alongside a Qigong master may generate a very different energy flow from what He and Chen may have experienced in the past.
He and Chen assert that the Qigong program is not individualized, and applies to all patients. This may be true in terms of tailoring to disease diagnosis. However, it is obvious from their discussion that there is actually much individual tailoring and monitoring of the program in the interaction between the patient and the Qigong master. Such individualization obviously cannot be implemented in a written Tumor Board. We also note with interest that they caution that the patient must really change their mentality and healing philosophy if they expect to heal with Qigong exercise: this correlates directly with the findings of Cunningham et al. in this issue. 9
Massage Therapy
The controversy about the safety of massage therapy for cancer patients has been under discussion in the alternative community for many years. A contraindication for massage on or too close to a lesion has a legitimate rationale. Direct massage of a tumor might activate cell proliferation and thus place a patient at risk. Avoiding areas in which metastases frequently occur with a particular type of cancer, eg the liver area in a breast cancer patient, might be of some value. However, this leaves much of the rest of the body free for the massage therapist to address, giving the cancer patient the possibility of receiving the substantial benefits of massage listed by Hovi. To date the issue of whether lymphatic drainage therapy increases lymphatic flow and actually impacts the ability of the body to diminish tumors is unclear. Hovi fortunately suggests several specific precautions that would have to be observed before implementing the technique. While the jury is out as to the real benefits of lymphatic drainage, we are pleased that the subject has been broached and heartily encourage readers with knowledge in this area to respond in writing and facilitate further discussion of the issue. Lastly, we offer a note of caution: adjustments or any sudden twisting of the body that places undue strain on bone or joints should be avoided where any possibility of metastatic involvement could exist.
Cancer Guides
Of particular interest in Henry Dreher's presentation were his accounts of experimental agents such as dendritic cell vaccines, and off-label uses of drugs, including celecoxib, copper chelators, and naltraxone-a discussion that did not appear in any of our other contributions in this tumor board. Together with the various herbal and supplement interventions he cited, these agents constitute an important new therapeutic arsenal for the patient combating malignant disease. One value of the Cancer Guides as Dreher describes them is in bringing these agents to the attention of a patient's treating physician, who can then better evaluate the treatment options available. However, the wisdom involved in determining whether a particular agent is the right match for a given patient lies in the knowledge base and clinical experience of the physician. Additionally, the unique clinical, biochemical and molecular picture of each patient must be understood before the right match can be made. In addition to the potential benefits and drawbacks of these innovative treatments themselves, there are also issues of interactions among chemotherapeutic and other treatments, and among treatments and herbs, supplements and nutritional parameters. Because the literature on new treatments is relatively scarce, clinical experience assumes more importance in their use than is the case with widely accepted agents.
Pastoral Counseling
One of the first points of Reverend McCray that should be understood in the context of contemporary pastoral counseling is that patients today see a hospital chaplain as someone with whom they can work on spiritual issues, regardless of whether the chaplain and patient are of the same religious denomination. Pastoral care is a matter of sensitivity in assisting patients in exploring their own spiritual issues, not of dictating doctrinal answers to spiritual questions. McCray exemplifies this sensitivity in many aspects of his contribution.
We concur, for instance, in his statement that the patient's response to disease will be colored by the support she has from spouse and family. We also find in clinical practice that psychological responses and ability to deal with the stresses of cancer treatment, as well as disease, can be strongly affected by such support. It is thus of great importance, as McCray points out, to explore with a patient more extended support sources including siblings or other family members, and church support groups or prayer groups. This support circle should be explored and their involvement established early in the treatment process, rather than waiting until a crisis arises.
The issue of reaction to recurrences is also raised in McCray's piece. While he mentions patients who become more resilient to diagnosis and treatment when they are diagnosed with a recurrence, we find that this is rare. More patients react, as McCray says, as if "a mountain had fallen on them." Many develop frank symptoms of posttraumatic stress disorder. But it is critical for the medical practitioner, as well as the pastoral counselor, to understand and adapt to the variability in reaction among patients. Approaching a patient who is consumed in anxiety and depression with an intellectually and emotionally challenging discussion of "the facts" is a guarantee of difficulty in months to come. Approaching a patient with paternalistic consolations and pats on the back when she is in fact ready to attack her disease, armed with literature citations, lists of questions, and bags of self-prescribed dietary supplements, is equally insensitive.
McCray's report provides a cogent discussion of why the medical profession's fear of giving patients false hope to advanced cancer patients is without merit. His metaphor of the person stranded on the roadside, out of gas (perhaps an updated setting of the Christian parable of the good Samaritan?) crystallizes the emotional plight of the patient whose physicians withhold the kind of hope McCray describes. This hope is not false information about the ability of the practitioner's conventional (or alternative) treatment to induce remissions, but rather a commitment to do all that can be done, and help the patient to search out all potential avenues for spiritual, emotional, and physical healing. It is a hope that is at the core of integrative cancer care.
